# US 2024/0182949 A1 · Methods of identifying multiple epitopes in cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0182949 A1
- Document ID: US20240182949A1
- Status: Published application
- Kind: A1
- Application number: 18/443,208
- Filed: 2024-02-15
- Published: 2024-06-06
- Earliest claimed: 2011-01-31
- Assignees: Roche Sequencing Solutions, Inc.
- Applicants: Roche Sequencing Solutions, Inc.
- Inventors: Garry P. Nolan
- Web page: https://patentgrep.com/patent/US20240182949A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.

## Claims

### Claim 1

A method for identifying whether a plurality of targets are in a plurality of cells comprising: binding to the targets a plurality of tags, wherein a tag comprises a code that represents a) the target identity and b) the identity of the cell in which tag is binding.

### Claim 2 (depends on 1)

The method of claim 1, wherein individual cell separation or isolation is unnecessary for the binding step.

### Claim 3

A method for identifying a single cell associated with a target comprising:
binding to the target a tag, wherein the tag comprises a code that represents
a) the target, and
b) the single cell;
wherein the during the binding the single cell is not isolated from a population of cells,
and
wherein the code that represents the single cell is unknown before the binding.

### Claim 4 (depends on 1, 2, 3)

The method of claims 1-3, further comprising detecting the code, wherein individual cell separation or isolation is unnecessary for the detecting step.

### Claim 5 (depends on 1, 2, 3, 4)

The method of claims 1-4, wherein each target is a protein or a nucleic acid.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method of claims 1-5, wherein the tag is a nucleic acid.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of claims 1-6, wherein the tag comprises a UBA.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of claims 1-7, wherein the UBA is specific for one of the targets.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of claims 1-8, wherein the tag comprises a UBA.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of claims 1-9, wherein the UBA comprises an antibody.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of claims 1-10, wherein the tag comprises a ESB.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method of claims 1-11, wherein the ESB comprises a common linker (CL).

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of claims 1-12, wherein the ESB codes the target identity.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of claims 1-13, wherein the ESB comprises a nucleic acid.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method of claims 1-14, wherein the tag comprises an APS.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method of claims 1-15, wherein the APS is detectable a detectably distinct coding unit.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The method of claims 1-16, wherein during the binding step multiple APSs are added to the tag in an ordered manner during successive rounds of split pool synthesis.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of claims 1-17, wherein the tag comprises at least 10 APSs.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The method of claims 1-18, wherein the APS comprises a nucleic acid.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The method of claims 1-19, wherein the tag comprises multiple APSs, an ESB, and a UBA linked by ligation.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The method of claims 1-20, wherein multiple APSs, the ESB, and/or the UBA is capable of being linked Click chemistry.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The method of claims 1-21, wherein the APS or the ESB comprises an amplification primer binding region.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The method of claims 1-22, wherein the UBA, ESB, or APS is templatable.

### Claim 24

A composition comprising:
a) a first target molecule,
b) a first unique binding agent (UBA) specific for the first target molecule,
c) a first linkable UBA-dependent epitope specific barcode (ESB), and
d) a plurality of ordered assayable polymer subunit (APS), wherein the order of APSs is detectable.

### Claim 25 (depends on 24)

The composition of claim 24, wherein the target molecule is selected from the group consisting of a peptide, a polypeptide, an oligopeptide, a protein, a phosphoprotein, an antibody, a nucleic acid, a peptide nucleic acid, a synthetic small molecule, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a lipid, a steroid, and a phospholipid.

### Claim 26

A composition comprising a population of particles each comprising at least a first target molecule, wherein the first target molecule is associated with:
(a) a first unique binding agent (UBA) specific for the first target molecule,
(b) a first linkable UBA-dependent epitope specific barcode (ESB), and
(c) a first plurality of ordered assayable polymer subunits (APS),
wherein the plurality of ordered APSs associated with the first target molecule of a first particle in the population is detectably different than the plurality of ordered APSs associated with the first target molecule of a second particle in the population.

### Claim 27 (depends on 24, 25, 26)

The composition of claims 24-26, wherein the plurality of ordered APSs comprises 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 APSs.

### Claim 28 (depends on 24, 25, 26, 27)

The composition of claims 24-27, wherein the plurality of ordered APSs comprises more than 20 APSs.

### Claim 29 (depends on 24, 25, 26, 27, 28)

The composition of claims 24-28, wherein the APSs are templatable.

### Claim 30 (depends on 26, 27, 28, 29)

The composition of claims 26-29, wherein at least one particle is selected from the group consisting of a cell, a liposome, an organelle, a micelle, a droplet and a bead.

### Claim 31 (depends on 26, 27, 28, 29, 30)

The composition of claims 26-30, wherein the target molecule is selected from the group consisting of a peptide, a polypeptide, an oligopeptide, a protein, a phosphoprotein, an antibody, a nucleic acid, a peptide nucleic acid, a synthetic small molecule, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a lipid, a steroid, and a phospholipid

### Claim 32 (depends on 24, 25, 26, 27, 28, 29, 30, 31)

The composition of claims 24-31, wherein the first ESB comprises a first common linker (CL).

### Claim 33 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32)

The composition of claims 24-32, wherein said first target molecule is directly bound to said first UBA and said first ESB is directly bound to said first UBA.

### Claim 34 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The composition of claims 24-33, wherein the plurality of ordered APS is formed by stepwise addition of APSs in separate rounds.

### Claim 35

The composition of 34, wherein the APS added on each round is linked to the first complex.

### Claim 36 (depends on 34, 35)

The composition of claim 34-35, wherein the linking is in order of rounds.

### Claim 37 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The composition of claims 24-36, wherein the linking of an APS, an ESB, or a UBA is performed using chemical methods.

### Claim 38 (depends on 37)

The composition of claim 37, wherein the chemical method comprises Click chemistry.

### Claim 39 (depends on 35, 36, 37, 38)

The composition of claims 35-38, wherein the linking is performed in the presence of CuI.

### Claim 40 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The composition of claims 24-39, wherein a UBA, an APS, or an ESB comprises nucleic acids.

### Claim 41

The composition of 40, further comprising a first linking oligonucleotide comprising a first and a second complementary region to two components selected from a UBA, an APS, and an ESB.

### Claim 42 (depends on 40, 41)

The composition of claims 40-41, wherein a UBA, an APS, or an ESB is linked using a linking oligonucleotide comprising the first and the second complementary region to two components selected from a UBA, an APS, and an ESB.

### Claim 43 (depends on 40, 41, 42)

The composition of claims 40-42, further comprising a second linking oligonucleotide comprising a third and a fourth complementary region to two components selected from a UBA, an APS, and an ESB.

### Claim 44 (depends on 40, 41, 42, 43)

The composition of claims 40-43, wherein a UBA, an APS, or an ESB is linked using a linking oligonucleotide comprising the third and the fourth complementary region to two components selected from a UBA, an APS, and an ESB.

### Claim 45 (depends on 43, 44)

The composition of claims 43-44, wherein the second and fourth complementary regions are identical.

### Claim 46 (depends on 43, 44, 45)

The composition of claims 43-45, wherein the second and fourth complementary regions are identical.

### Claim 47 (depends on 41, 42, 43, 44, 45, 46)

The composition of claims 41-46, wherein the first or second complementary region is shared between two APSs within the plurality of APSs.

### Claim 48 (depends on 42, 43, 44, 45, 46, 47)

The composition of claim 42-47, wherein the linking is performed by ligation.

### Claim 49 (depends on 41, 42, 43, 44, 45, 46, 47, 48)

The composition of claims 41-48, wherein the linking oligonucleotide comprises a subcode encoding the origin of the APS or the ESB.

### Claim 50 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The composition of claims 24-49, wherein the APS has a subcode encoding the origin of the APS.

### Claim 51 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50)

The composition of claims 24-50, wherein the ESB has a subcode encoding the origin of the ESB.

### Claim 52 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)

The composition of claims 24-51, wherein an individual APS, ESB, or linking oligonucleotide molecule comprises a unique counter tag.

### Claim 53 (depends on 52)

The composition of claim 52, wherein the unique counter tag is detectable.

### Claim 54 (depends on 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The composition of claims 41-53, wherein the ESB is covalently linked to the linking oligonucleotide.

### Claim 55 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The composition of claims 24-54, wherein an APS or an ESB comprises an amplification primer binding region.

### Claim 56 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

The composition of claims 24-55, wherein the APSs and ESB, when linked, are capable of encoding a secondary product.

### Claim 57 (depends on 56)

The composition of claim 56, wherein the secondary product is an RNA or a peptide.

### Claim 58 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The composition of claims 24-57, wherein the APSs and ESB, when linked, comprises a polymerase start site.

### Claim 59 (depends on 57, 58)

The composition of claims 57-58, wherein the peptide comprises an affinity tag.

### Claim 60 (depends on 59)

The composition of claim 59, wherein the affinity tag is a His-tag.

### Claim 61 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The composition of claims 24-60, wherein the UBA, ESB, or APS is templatable.

### Claim 62 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)

The composition of claims 24-61, further comprising a probe.

### Claim 63 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62)

The composition of claims 24-62, wherein the probe is attached to a surface.

### Claim 64 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63)

The composition of claims 24-63, wherein the surface comprises an array.

### Claim 65 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The composition of claims 24-64, wherein the surface comprises a bead.

### Claim 66 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The composition of claims 24-65, wherein the UBA is selected from the group consisting of antibody, peptide, aptamer, peptoid and nucleic acid.

### Claim 67 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66)

The composition of claims 24-66, wherein the ESB is selected from the group consisting of nucleic acids, beads and chemical subunits.

### Claim 68 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67)

The composition of claims 24-67, wherein said APS comprises a nucleic acid, a small molecule, or buildable complex molecules of deterministic weight.

### Claim 69

A kit for labeling a target molecule of a cell in a population of cells with a cell origination barcode, comprising
(a) n sets of m assayable polymer subunits (APSs) each comprising a distinct package of information; wherein the packages of information are capable of being linked in an ordered fashion;
(b) a target molecule-specific unique binding agent (UBA).

### Claim 70

A kit for labeling a target molecule of a cell in a population of cells with a cell origination barcode, comprising
(a) n sets of m assayable polymer subunits (APSs) each comprising a distinct package of information; wherein the packages of information are capable of being linked in an ordered fashion;
(b) a plurality of target molecule-specific unique binding agents (UBA) each linked with a UBA-specific epitope specific barcode (ESB).

### Claim 71

A kit for labeling a target molecule of a cell in a population of cells with a cell origination barcode, comprising
(a) n sets of m assayable polymer subunits (APSs) each comprising a distinct package of information; wherein the packages of information are capable of being linked in an ordered fashion;
(b) a plurality of target molecule-specific unique binding agents (UBA);
(c) a plurality of UBA-specific epitope specific barcode (ESB), wherein each ESB is capable of linking with a designated UBA.

### Claim 72 (depends on 69, 70, 71)

The kit of claims 69-71, wherein n is 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 73 (depends on 69, 70, 71, 72)

The kit of claims 69-72, wherein m is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20.

### Claim 74 (depends on 69, 70, 71, 72, 73)

The kit of claims 69-73, wherein n is greater than 10.

### Claim 75 (depends on 69, 70, 71, 72, 73, 74)

The kit of claims 69-74, wherein m is greater than 20.

### Claim 76 (depends on 70, 71, 72, 73, 74, 75)

The kit of claim 70-75, wherein the first ESB comprises a first common linker (CL).

### Claim 77 (depends on 70, 71, 72, 73, 74, 75, 76)

The kit of claim 70-76, wherein said ESB is capable of directly binding to said UBA.

### Claim 78 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77)

The kit of claims 69-77, wherein said UBA is capable of directly binding to the target molecule.

### Claim 79 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78)

The kit of claims 69-78, wherein at least two of the assayable polymer subunit (APS) sets are identical.

### Claim 80 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79)

The kit of claims 69-79, wherein the APSs in a first set is linkable to the APSs in a second set.

### Claim 81 (depends on 80)

The kit of claim 80, the APSs in a first set is further linkable to the APSs in a second set in an ordered fashion.

### Claim 82 (depends on 79, 80, 81)

The kit of claims 79-81, wherein an APS, an ESB, or a UBA is capable of being linked using chemical methods.

### Claim 83 (depends on 82)

The kit of claim 82, wherein the chemical method comprises Click chemistry.

### Claim 84 (depends on 82, 83)

The kit of claims 82-83, wherein the presence of CuI is required for linkage.

### Claim 85 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84)

The kit of claims 69-84, wherein a UBA, an APS, or an ESB comprises nucleic acids.

### Claim 86 (depends on 85)

The kit of claim 85, further comprising a first linking oligonucleotide comprising a first and a second complementary region to two components selected from a UBA, an APS, and an ESB.

### Claim 87 (depends on 86)

The kit of claim 86, further comprising a second linking oligonucleotide comprising a third and a fourth complementary region to two components selected from a UBA, an APS, and an ESB.

### Claim 88 (depends on 87)

The kit of claim 87, wherein the first and third complementary regions are identical.

### Claim 89 (depends on 86, 87)

The kit of claims 86-87, wherein the second and fourth complementary regions are identical.

### Claim 90 (depends on 85, 86, 87, 88, 89)

The kit of claims 85-89, an APS, an ESB, or a UBA is capable of being linked by ligation.

### Claim 91 (depends on 86, 87, 88, 89, 90)

The kit of claims 86-90, wherein the linking oligonucleotide comprises a subcode encoding the original set of the APS or the ESB.

### Claim 92 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91)

The kit of claims 69-91, wherein the APS has a subcode encoding the origin population of the APS.

### Claim 93 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92)

The kit of claims 69-92, wherein the ESB has a subcode encoding the origin population of the ESB.

### Claim 94 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93)

The kit of claims 69-93, wherein an individual APS, ESB, or linking oligonucleotide molecule comprises a unique counter tag.

### Claim 95 (depends on 94)

The kit of claim 94, wherein the unique counter tag is detectable.

### Claim 96 (depends on 86, 87, 88, 89, 90, 91, 92, 93, 94, 95)

The kit of claims 86-95, wherein the ESB is covalently linked to the linking oligonucleotide.

### Claim 97 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96)

The kit of claims 69-96, wherein an APS or an ESB comprises an amplification primer binding region.

### Claim 98 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97)

The kit of claims 69-97, wherein the APSs and ESB, when linked, are capable of encoding a secondary product.

### Claim 99 (depends on 98)

The kit of claim 98, wherein the secondary product is an RNA or a peptide.

### Claim 100 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99)

The kit of claims 69-99, wherein the APSs and ESB, when linked, comprises a polymerase start site.

### Claim 101 (depends on 99, 100)

The kit of claims 99-100, wherein the peptide comprises an affinity tag.

### Claim 102 (depends on 101)

The kit of claim 101, wherein the affinity tag is a His-tag.

### Claim 103 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102)

The kit of claims 69-102, wherein the UBA, ESB, or APS is templatable.

### Claim 104 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103)

The kit of claims 69-103, further comprising a probe.

### Claim 105 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104)

The kit of claims 69-104, wherein the probe is attached to a surface.

### Claim 106 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105)

The kit of claims 69-105, wherein the surface comprises an array.

### Claim 107 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106)

The kit of claims 69-106, wherein the surface comprises a bead.

### Claim 108 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107)

The kit of claims 69-107, wherein the plurality of UBAs comprises 2, 3, 4, 5, 10, 20, 30, 50, 100, 200, 300, 500, 600, 700, 800, 900, 1000 or more than 1000 UBAs.

### Claim 109 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108)

The kit of claims 69-108, wherein the plurality of UBAs comprises up to 2000 UBAs.

### Claim 110 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109)

The kit of claims 69-109, wherein the UBA is selected from the group consisting of antibody, peptide, aptamer, peptoid and nucleic acid.

### Claim 111 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110)

The kit of claims 69-110, wherein the ESB is selected from the group consisting of nucleic acids, beads and chemical subunits.

### Claim 112 (depends on 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111)

The kit of claims 69-111, wherein said APS comprises a nucleic acid, a small molecule, or buildable complex molecules of deterministic weight.

### Claim 113

A method for identifying target molecules sharing a common particle origin, comprising labeling a first plurality of targets of a first particle in a population of x particles with a first origination barcode; and
labeling a second plurality of targets of a second particle in a population of x particles with a second origination barcode;
wherein each origination barcode comprises a set of n assayable polymer subunits (APS);
wherein each of the n APSs in the first and second set of APSs is selected from a group comprising m different APSs; and
wherein the first and second origination barcodes are detectably different from each other with a certainty of c=1−[(1−1/x){circumflex over ( )}(mn)].

### Claim 114 (depends on 113)

The method of claim 113, wherein x is greater than 1,000,000.

### Claim 115 (depends on 113, 114)

The method of claims 113-114, wherein c is greater than 99.9%.

### Claim 116 (depends on 113, 114, 115)

The method of claims 113-115, wherein c is greater than 99.99%.

### Claim 117 (depends on 113, 114, 115, 116)

The method of claims 113-116, wherein c is greater than 99.999%.

### Claim 118 (depends on 113, 114, 115, 116, 117)

The method of claims 113-117, wherein c is greater than 99.9999%.

### Claim 119 (depends on 113, 114, 115, 116, 117, 118)

The method of claims 113-118, wherein c is greater than 99.99999%.

### Claim 120 (depends on 113, 114, 115, 116, 117, 118, 119)

The method of claims 113-119, wherein n is 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 121 (depends on 113, 114, 115, 116, 117, 118, 119, 120)

The method of claims 113-120, wherein m is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20.

### Claim 122 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121)

The method of claims 113-121, wherein n is greater than 10.

### Claim 123 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121, 122)

The method of claims 113-122, wherein m is greater than 20.

### Claim 124 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123)

The method of claims 113-123, wherein at least one discrete particle is selected from the group consisting of a cell, a liposome, an organelle, a micelle, a droplet and a bead.

### Claim 125 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124)

The method of claims 113-124, wherein the target molecule is selected from the group consisting of a peptide, a polypeptide, an oligopeptide, a protein, a phosphoprotein, an antibody, a nucleic acid, a peptide nucleic acid, a synthetic small molecule, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a lipid, a steroid, and a phospholipid.

### Claim 126 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125)

The method of claims 113-125, wherein at least two groups comprising m different APSs are identical.

### Claim 127 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126)

The method of claims 113-126, wherein the n APSs are added in separate rounds.

### Claim 128 (depends on 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127)

The method of claims 113-127, wherein the APSs of separate rounds are linked.

### Claim 129 (depends on 128)

The method of claim 128, wherein the linking is in order of rounds.

### Claim 130

A method of imparting a particle specific code to a component of a particle of a population of particles, the method comprising:
linking a first ordered set of assayable polymer subunits (APS) to a first component of a first particle of a population of particles, wherein the order of the APSs is detectable by a detection method.

### Claim 131 (depends on 130)

The method of claim 130, further comprising detecting the first ordered set of APSs linked with the first component, thereby determining a particle origin of the first component.

### Claim 132 (depends on 130, 131)

The method of claims 130-131, further comprising linking a second ordered set of assayable polymer subunits (APS) to a second component of the first particle of a population of particles, wherein the order of the APSs is detectable.

### Claim 133 (depends on 132)

The method of claim 132, further comprising detecting the second ordered set of APSs linked with the second component, thereby determining the particle origin of the second component.

### Claim 134 (depends on 130, 131, 132, 133)

The method of claims 130-133, wherein the first and the second ordered sets of APSs linked with the first and second components of the first particle are the same.

### Claim 135 (depends on 130, 131, 132, 133, 134)

The method of claims 130-134, further comprising linking a third ordered set of assayable polymer subunits (APS) to a first component of second particle of a population of particles, wherein the order of the APSs is detectable.

### Claim 136 (depends on 135)

The method of claim 135, wherein the first ordered set of APSs linked with the first component of the first particle is different than the third ordered set of assayable polymer subunits linked with the first component of the second particle.

### Claim 137 (depends on 130, 131, 132, 133, 134, 135, 136)

The method of claims 130-136, further comprising linking a component specific epitope specific barcode (ESB) to the first component.

### Claim 138 (depends on 130, 131, 132, 133, 134, 135, 136, 137)

The method of claims 130-137, further comprising linking a component specific ESB to the second component.

### Claim 139 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138)

The method of claims 130-138, wherein at least the particle is selected from the group consisting of a cell, a liposome, an organelle, a micelle, a droplet and a bead.

### Claim 140 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139)

The method of claims 130-139, wherein said at least one target molecule is directly bound to said first UBA and said ESB is directly bound to said UBA.

### Claim 141 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140)

The method of claims 130-140, wherein at least two of the assayable polymer subunit (APS) sets are identical.

### Claim 142 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141)

The method of claims 130-141, wherein each APS from the ordered set of APSs is linked to the first complex.

### Claim 143 (depends on 142)

The method of claim 142, wherein the linking is in order of rounds.

### Claim 144 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143)

The method of claims 130-143, wherein the UBA, ESB, or APS encodes a secondary product.

### Claim 145 (depends on 144)

The method of claim 144, wherein the secondary product is an RNA or a peptide.

### Claim 146 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145)

The method claims 130-145, wherein the UBA, ESB, or APS is templatable.

### Claim 147 (depends on 137, 138, 139, 140, 141, 142, 143, 144, 145, 146)

The method of claims 137-146, wherein the ESB further comprises a unique counter tag.

### Claim 148 (depends on 147)

The method of claim 147, wherein the quantity of the target molecule of the molecule is estimated using the counter tag.

### Claim 149 (depends on 143, 144, 145, 146, 147, 148)

The method of any preceding claims 143-148, wherein the APS further comprises a round-specific subcode.

### Claim 150 (depends on 149)

The method of claim 149, wherein the detection further comprises determining the presence of an APS from a designated round.

### Claim 151 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150)

The method of claims 130-150, wherein detection is digital.

### Claim 152 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151)

The method of claims 130-151, wherein detection is indirect.

### Claim 153 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152)

The method of claims 130-152, wherein detecting comprises mass spectrometry.

### Claim 154 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153)

The method of claims 130-153, wherein detecting comprises nucleic acid sequencing.

### Claim 155 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154)

The method of claims 130-154, wherein detecting comprises peptide sequencing.

### Claim 156 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155)

The method of claims 130-155, wherein detecting comprises mass gel electrophoresis.

### Claim 157 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156)

The method of claims 130-156, wherein detecting comprises HPLC or other chromatographic separation.

### Claim 158 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157)

The method of claims 130-157, wherein detecting comprises detecting one or more signals associated with one or more individual APSs.

### Claim 159 (depends on 158)

The method of claim 158, wherein the signals are ordered.

### Claim 160 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159)

The method of claims 130-159, wherein detecting comprises using one or more probes.

### Claim 161 (depends on 160)

The method of claim 160, wherein the probe is attached to a surface.

### Claim 162 (depends on 161)

The method of claim 161, wherein the surface comprises an array.

### Claim 163 (depends on 161)

The method of claim 161, wherein the surface comprises a bead.

### Claim 164 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163)

The method of claims 130-163, wherein detecting comprises a separation.

### Claim 165 (depends on 164)

The method of claim 164, wherein the separation is multi-dimensional.

### Claim 166 (depends on 164, 165)

The method of claims 164-165, wherein the separation resolves the first linkable UBA-dependent epitope specific barcode (ESB) from a second linkable UBA-dependent epitope specific barcode (ESB).

### Claim 167 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166)

The method of claims 130-166, wherein 3, 4, 5, 10, 20, 30, 50, 100, 200, 300, 500, 600, 700, 800, 900, 1000 or more than 1000 different target molecules are detected.

### Claim 168 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167)

The method of claims 130-167, wherein up to 2000 different target molecules are detected.

### Claim 169 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168)

The method of claims 130-168, wherein the UBA is selected from the group consisting of antibody, peptide, aptamer, peptoid and nucleic acid.

### Claim 170 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169)

The method of claims 130-169, wherein the ESB is selected from the group consisting of nucleic acids, beads and chemical subunits.

### Claim 171 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170)

The method of claims 130-170, wherein said APS comprises a nucleic acid, a small molecule, or buildable complex molecules of deterministic weight.

### Claim 172 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171)

The method of claims 130-171, wherein the APSs are linked to through ligation or extension via polymerization.

### Claim 173 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172)

The method of claims 130-172, wherein a cell origination barcode (COB) is generated with the APSs from the ordered set of APSs.

### Claim 174 (depends on 173)

The method of claim 173, wherein each COB in said plurality of complexes has a detectable signal or sequence that distinguishes it from other COBs in said population of cells.

### Claim 175 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174)

The method of claims 130-174, wherein an APS, an ESB, or a UBA is linked using chemical methods.

### Claim 176 (depends on 175)

The method of claim 175, wherein the chemical method comprises Click chemistry.

### Claim 177 (depends on 175, 176)

The method of claims 175-176, wherein the linking is performed in the presence of CuI.

### Claim 178 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177)

The method of claims 130-177, wherein a UBA, an APS, or an ESB comprises nucleic acids.

### Claim 179 (depends on 178)

The method of claim 178, wherein the linking of a UBA, an APS, or an ESB is performed using a linking oligonucleotide that comprises a first and a second complementary region to two components to be linked.

### Claim 180 (depends on 179)

The method of claim 179, wherein the first or second complementary region is shared between APSs within a population of APSs.

### Claim 181 (depends on 179, 180)

The method of claim 179-180, wherein the first or second complementary region is distinct for two different round-specific sets of APSs.

### Claim 182 (depends on 179, 180, 181)

The method of claim 179-181, further comprising ligation.

### Claim 183 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182)

The method of claims 130-182, wherein the target molecule is selected from the group consisting of a peptide, a polypeptide, an oligopeptide, a protein, a phosphoprotein, an antibody, a nucleic acid, a peptide nucleic acid, a synthetic small molecule, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a lipid, a steroid, and a phospholipid.

### Claim 184 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183)

The method of claims 130-183, wherein the first ESB comprises a first common linker (CL).

### Claim 185 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184)

The method of claims 130-184, wherein the first ESB comprises a first common linker (CL).

### Claim 186 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185)

The method of claims 130-185, wherein an individual APS, ESB, or linking oligonucleotide molecule comprises a unique counter tag.

### Claim 187 (depends on 186)

The method of claim 186, wherein detection comprises detecting the unique counter tag.

### Claim 188 (depends on 187)

The method of claim 187, wherein the number of unique counter tags associated with a specific ESB is determined.

### Claim 189 (depends on 188)

The method of claim 188, wherein the number of detected unique counter tags relate to the initial quantity of the specific ESB.

### Claim 190 (depends on 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189)

The method of claims 179-189, wherein the ESB is covalently linked to the linking oligonucleotide.

### Claim 191 (depends on 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190)

The method of claims 130-190, wherein an APS or an ESB comprises an amplification primer binding region.

### Claim 192 (depends on 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191)

The method of claims 173-191, wherein a COB encodes a peptide sequence.

### Claim 193 (depends on 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192)

The method of claims 173-192, wherein the COB comprises a polymerase start site.

### Claim 194 (depends on 192, 193)

The method of claims 192-193, wherein the peptide comprises an affinity tag.

### Claim 195 (depends on 194)

The method of claim 194, wherein the affinity tag is a His-tag.

### Claim 196

A method for detecting a plurality of properties originating from a plurality of discrete particles, the method comprising:
a) providing:
i) a population of particles comprising at least a first target molecule;
ii) a first unique binding agent (UBA) specific for the first target molecule;
iii) a first linkable UBA-dependent epitope specific barcode (ESB);
iv) a plurality of round-specific assayable polymer subunit (APS) sets, each set containing a plurality of APSs that are detectably distinct from each other;
b) forming at least a first complex comprising said at least first target molecule, said first UBA probe, and said first ESB;
c) performing n rounds of split pool synthesis, each round comprising;
i) splitting the population of particles into m reaction volumes;
ii) contacting one or more reaction volumes with an APS from the APS set specific for the round;
iii) pooling two or more reaction volumes;
d) detecting a plurality of properties from at least one particle from the population of particles;
wherein at least one of the properties relate to a quantity or an identity for a target molecule associated with the particle.

### Claim 197

A method for detecting a plurality of properties originating from a plurality of discrete particles, the method comprising:
a) providing:
i) a population of particles comprising at least a first target molecule;
ii) a first unique binding agent (UBA) specific for the first target molecule;
iii) a first linkable UBA-dependent epitope specific barcode (ESB); and
iv) a plurality of round-specific assayable polymer subunit (APS) sets, each set containing a plurality of APSs that are detectably distinct from each other;
b) forming at least a first complex comprising said at least first target molecule, said first UBA probe, and said first ESB;
c) performing n rounds of split pool synthesis, each round comprising:
i) splitting the population of particles into m reaction volumes;
ii) contacting one or more reaction volumes with an APS from the APS set specific for the round; and
iii) pooling two or more reaction volumes;
d) performing another round of split pool synthesis comprising steps c) i) and c) ii);
e) detecting a plurality of properties from at least one particle from the population of particles;
wherein at least one of the properties relate to a quantity or an identity for a target molecule associated with the particle.

### Claim 198 (depends on 196, 197)

The method of claims 196-197, wherein n is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20.

### Claim 199 (depends on 196, 197, 198)

The method of claims 196-198, wherein n is more than 20.

### Claim 200 (depends on 196, 197, 198, 199)

The method of claims 196-199, wherein m is different between at least two rounds.

### Claim 201 (depends on 196, 197, 198, 199, 200)

The method of claims 196-200, wherein m is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20.

### Claim 202 (depends on 196, 197, 198, 199, 200, 201)

The method of claims 196-201, wherein m is more than 20.

### Claim 203 (depends on 196, 197, 198, 199, 200, 201, 202)

The method of claims 196-202, wherein at least one discrete particle is selected from the group consisting of a cell, a liposome, an organelle, a micelle, a droplet and a bead.

### Claim 204 (depends on 196, 197, 198, 199, 200, 201, 202, 203)

The method of claims 196-203, wherein the target molecule is selected from the group consisting of a peptide, a polypeptide, an oligopeptide, a protein, a phosphoprotein, an antibody, a nucleic acid, a peptide nucleic acid, a synthetic small molecule, a disaccharide, a trisaccharide, an oligosaccharide, a polysaccharide, a lipid, a steroid, and a phospholipid.

### Claim 205 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204)

The method of claims 196-204, wherein the first ESB comprises a first common linker (CL).

### Claim 206 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205)

The method of claims 196-205, wherein said at least one target molecule is directly bound to said first UBA and said ESB is directly bound to said UBA.

### Claim 207 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206)

The method of claims 196-206, wherein at least two of the assayable polymer subunit (APS) sets are identical.

### Claim 208 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207)

The method of claims 196-207, wherein the APS added on each round is linked to the first complex.

### Claim 209 (depends on 208)

The method of claim 208, wherein the linking is in order of rounds.

### Claim 210 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209)

The method of claims 196-209, wherein the UBA, ESB, or APS encodes a secondary product.

### Claim 211 (depends on 210)

The method of claim 210, wherein the secondary product is an RNA or a peptide.

### Claim 212 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211)

The method of claims 196-211, wherein the UBA, ESB, or APS is templatable.

### Claim 213 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212)

The method of claims 196-212, wherein the ESB further comprises a unique counter tag.

### Claim 214 (depends on 213)

The method of claim 213, wherein the quantity of the target molecule of the molecule is estimated using the counter tag.

### Claim 215 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214)

The method of claims 196-214, wherein the APS further comprises a round-specific subcode.

### Claim 216 (depends on 215)

The method of claim 215, wherein the detection further comprises determining the presence of an APS from a designated round.

### Claim 217 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216)

The method of claims 196-216, wherein detection is digital.

### Claim 218 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217)

The method of claims 196-217, wherein detection is indirect.

### Claim 219 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218)

The method of claims 196-218, wherein detecting comprises mass spectrometry.

### Claim 220 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219)

The method of claims 196-219, wherein detecting comprises nucleic acid sequencing.

### Claim 221 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220)

The method of claims 196-220, wherein detecting comprises peptide sequencing.

### Claim 222 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221)

The method of claims 196-221, wherein detecting comprises detecting one or more signals associated with one or more individual APSs.

### Claim 223 (depends on 222)

The method of claim 222, wherein the signals are ordered.

### Claim 224 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223)

The method of claims 196-223, wherein detecting comprises using one or more probes.

### Claim 225 (depends on 224)

The method of claim 224, wherein the probe is attached to a surface.

### Claim 226 (depends on 225)

The method of claim 225, wherein the surface comprises an array.

### Claim 227 (depends on 225)

The method of claim 225, wherein the surface comprises a bead.

### Claim 228 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227)

The method of claims 196-227, wherein detecting comprises a separation.

### Claim 229 (depends on 228)

The method of claim 228, wherein the separation is multi-dimensional.

### Claim 230 (depends on 228, 229)

The method of claims 228-229, wherein the separation resolves the first linkable UBA-dependent epitope specific barcode (ESB) from a second linkable UBA-dependent epitope specific barcode (ESB).

### Claim 231 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230)

The method of claims 196-230, wherein 3, 4, 5, 10, 20, 30, 50, 100, 200, 300, 500, 600, 700, 800, 900, 1000 or more than 1000 different target molecules are detected.

### Claim 232 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231)

The method of claims 196-231, wherein up to 2000 different target molecules are detected.

### Claim 233 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232)

The method of claims 196-232, wherein the UBA is selected from the group consisting of antibody, peptide, aptamer, peptoid and nucleic acid.

### Claim 234 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233)

The method of claims 196-233, wherein the ESB is selected from the group consisting of nucleic acids, beads and chemical subunits.

### Claim 235 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234)

The method of claims 196-234, wherein said APS comprises a nucleic acid, a small molecule, or buildable complex molecules of deterministic weight.

### Claim 236 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235)

The method of claims 196-235, wherein the APSs are linked to through ligation or extension via polymerization.

### Claim 237 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236)

The method of claims 196-236, wherein a cell origination barcode (COB) is generated from APSs of round specific APS sets.

### Claim 238 (depends on 237)

The method of claim 237, wherein each COB in said plurality of complexes has a detectable signal or sequence that distinguishes it from other COBs in said population of cells.

### Claim 239 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238)

The method of claims 196-238, wherein an APS, an ESB, or a UBA is linked using chemical methods.

### Claim 240 (depends on 239)

The method of claim 239, wherein the chemical method comprises Click chemistry.

### Claim 241 (depends on 239, 240)

The method of claims 239-240, wherein the linking is performed in the presence of CuI.

### Claim 242 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241)

The method of claims 196-241, wherein a UBA, an APS, or an ESB comprises nucleic acids.

### Claim 243 (depends on 242)

The method of claim 242, wherein the linking of a UBA, an APS, or an ESB is performed using a linking oligonucleotide that comprises a first and a second complementary region to two components to be linked.

### Claim 244 (depends on 243)

The method of claim 243, wherein the first or second complementary region is shared between APSs within a population of APSs.

### Claim 245 (depends on 243, 244)

The method of claim 243-244, wherein the first or second complementary region is distinct for two different round-specific sets of APSs.

### Claim 246 (depends on 243, 244, 245)

The method of claim 243-245, further comprising ligation.

### Claim 247 (depends on 243, 244, 245, 246)

The method of claims 243-246, wherein the linking oligonucleotide comprises a subcode encoding the origin population of the APS or the ESB.

### Claim 248 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247)

The method of claims 196-247, wherein the APS has a subcode encoding the round-specific set of the APS.

### Claim 249 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248)

The method of claims 196-248, wherein the ESB has a subcode encoding the origin presence of the ESB.

### Claim 250 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249)

The method of claims 196-249, wherein an individual APS, ESB, or linking oligonucleotide molecule comprises a unique counter tag.

### Claim 251 (depends on 250)

The method of claim 250, wherein detection comprises detecting the unique counter tag.

### Claim 252 (depends on 251)

The method of claim 251, wherein the number of unique counter tags associated with a specific ESB is determined.

### Claim 253 (depends on 252)

The method of claim 252, wherein the number of detected unique counter tags relate to the initial quantity of the specific ESB.

### Claim 254 (depends on 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253)

The method of claims 243-253, wherein the ESB is covalently linked to the linking oligonucleotide.

### Claim 255 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254)

The method of claims 196-254, wherein an APS or an ESB comprises an amplification primer binding region.

### Claim 256 (depends on 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255)

The method of claims 237-255, wherein a COB encodes a peptide sequence.

### Claim 257 (depends on 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256)

The method of claims 237-256, wherein the COB comprises a polymerase start site.

### Claim 258 (depends on 256, 257)

The method of claims 256-257, wherein the peptide comprises an affinity tag.

### Claim 259 (depends on 258)

The method of claim 258, wherein the affinity tag is a His-tag.

### Claim 260 (depends on 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259)

The method of claims 196-259, wherein each of the reaction volumes created by the most recent splitting receives a different APS from the APS set.

### Claim 261

A method for detecting at least one target molecule in a sample comprising the steps:
(a) providing:
(i) a population of cells potentially comprising at least one target molecule,
(ii) a first unique binding agent (UBA) specific for a first target molecule,
(iii) a first epitope specific barcode (ESB) specific for a region of said first UBA, wherein said ESB comprises a first common linker moiety, and
(iv) a population of assayable polymer subunits (APSs), wherein said APSs comprises a second common linker moiety and a third common linker moiety, wherein said second linker moiety is complementary to said first common linker moiety is said first ESB;
(b) forming at least a first complex comprising said at least one target molecule, said first UBA probe, and said first ESB, wherein said at least one target molecule is bound to said first UBA and said ESB is bound to said UBA;
(c) splitting said population into two or more samples;
(d) adding one APS from said population of APSs per sample to said two or more samples from step (c), wherein a second complex is formed with said least one target molecule, said first UBA probe, said first ESB, and a first APS, and wherein said second common linker moiety from said first APS is bound to said first linker moiety from said first ESB;
(e) pooling said two or more samples from step (c) into one sample;
(f) splitting said sample from step (e) into two or more samples;
(g) adding one APS from said population of APSs per sample to said two or more samples from step (e), wherein a third complex is formed with said least one target molecule, said first UBA probe, said first ESB, said first APS, and said second APS, wherein said second common linker moiety from said second APS is bound to said third linker moiety from said first APS, and wherein said first APS and said second APS form a cell origination barcode (COB); and
(c) detecting said third complex or at least part of said third complex.

### Claim 262 (depends on 261)

The method of claim 261 further comprising repeating steps (e), through (g).

### Claim 263 (depends on 261)

The method of claim 261 further comprising detecting of a plurality of target molecules by a method comprising forming a plurality of complexes in step (b), each complex comprising (i) at least one target molecule (ii) a first UBA and (iii) a first epitope specific barcode (ESB) specific for a region of said first UBA, wherein said ESB comprises a first common linker moiety, wherein said at least one target molecule is bound to said first UBA and said ESB is bound to said UBA.

### Claim 264 (depends on 263)

The method of claim 263, wherein each COB in said plurality of complexes has a detectable signal or sequence that distinguishes it from other COB in said population of cells.

### Claim 265 (depends on 261, 262, 263, 264)

The method of claims 261-264, wherein said complex is detected by sequencing or mass spectrometry.

### Claim 266 (depends on 261)

The method of claim 261, wherein said third complex is detected by a method comprising individually counting the presence of one or more molecules of said third complex wherein the presence of said one or more molecules of said third complex is indicative of the concentration or presence of said target molecule in a cell.

### Claim 267 (depends on 266)

The method of claim 266, wherein said individually detecting further comprises detecting a digital signal.

### Claim 268 (depends on 263)

The method of claim 263, wherein 3, 4, 5, 10, 20, 30, 50, 100, 200, 300, 500, 600, 700, 800, 900, 1000 or more than 1000 different target molecules are detected.

### Claim 269 (depends on 263)

The method of claim 263, wherein up to 2000 different target molecules are detected.

### Claim 270 (depends on 261)

The method of claim 261, wherein said UBA comprises a structure selected from the group consisting of antibody, peptide, aptamer, peptoid and nucleic acid or any combination.

### Claim 271 (depends on 261)

The method of claim 261, wherein said ESB comprises a structure selected from the group consisting of nucleic acids, beads and chemical subunits or any combination.

### Claim 272 (depends on 261)

The method of claim 261, wherein said APS comprises a nucleic acid, a small molecule, or buildable complex molecules of deterministic weight.

### Claim 273 (depends on 261)

The method of claim 261, wherein said APS comprises a single-stranded nucleic acid hybridized to a complementary polynucleotide sequence having attached thereto a detectable label.

### Claim 274 (depends on 261)

The method of claim 261, wherein said first APS is attached to said first ESB through ligation or extension via polymerization.

### Claim 275 (depends on 261)

The method of claim 261, wherein said second APS is attached to said first APS through ligation or extension via polymerization.

### Claim 276 (depends on 261)

The method of claim 261, wherein said common linker moiety is a nucleic acid.

### Claim 277 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276)

The method of claims 261-276, wherein said ESB is attached to said USB.

### Claim 278

A method for detecting at least one target molecule in a sample comprising the steps:
(a) providing:
(i) a population of cells potentially comprising at least one target molecule
(ii) a first UBA specific for a first target molecule,
(iii) a first epitope specific barcode ESB specific for a region of said first UBA, wherein said ESB comprises a first common linker moiety, and
(iv) a population of COB, wherein said population of COB comprises a second common linker moiety, wherein said second linker moiety is complementary to said first common linker moiety is said first ESB;
(b) forming at least a first complex comprising said at least one target molecule, said first UBA probe, and said first ESB, wherein said at least one target molecule is bound to said first UBA and said ESB is bound to said UBA;
(c) adding said population of COBs, wherein a second complex is formed with said least one target molecule, said first UBA probe, said first ESB, and a first COB, and wherein said second common linker moiety from said first COB is bound to said first linker moiety from said first ESB, and wherein the COBs from said population of COBs is associated with a cell from said population of cells; and
(d) detecting said second complex or at least part of said third complex.

### Claim 279 (depends on 278)

The method of claim 278, wherein said first COB comprises a plurality of APS.

### Claim 280 (depends on 278)

The method of claim 278, further comprising detecting of a plurality of target molecules by a method comprising:
forming a plurality of complexes in step (b), each complex comprising (i) at least one target molecule (ii) a first UBA and (iii) a first epitope specific barcode (ESB) specific for a region of said first UBA, wherein said ESB comprises a first common linker moiety, wherein said at least one target molecule is associated with said first UBA and said ESB is associated with said UBA.

### Claim 281 (depends on 263)

The method of claim 263, wherein each COB in said plurality of complexes has a detectable signal or sequence that distinguishes it from other COBs in said population of cells.

### Claim 282 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281)

The method of claims 261-281, wherein the linking of an APS, an ESB, or a UBA is performed using chemical methods.

### Claim 283 (depends on 282)

The method of claim 282, wherein the chemical method comprises Click chemistry.

### Claim 284 (depends on 282, 283)

The method of claims 282-283, wherein the linking is performed in the presence of CuI.

### Claim 285 (depends on 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284)

The method of claims 264-284, wherein linking of an ABSm an ESB, or a UBA is performed using binding affinity.

### Claim 286 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285)

The method of claims 261-285, wherein a UBA, an APS, or an ESB comprises nucleic acids.

### Claim 287 (depends on 286)

The method of claim 286, wherein the linking of a UBA, an APS, or an ESB is performed using a linking oligonucleotide that comprises a first and a second complementary region to two components to be linked.

### Claim 288 (depends on 287)

The method of claim 287, wherein the first or second complementary region is shared between APSs within a population of APSs.

### Claim 289 (depends on 287, 288)

The method of claim 287-288, wherein the first or second complementary region is distinct for different populations of APSs.

### Claim 290 (depends on 287, 288, 289)

The method of claims 287-289, further comprising ligation.

### Claim 291 (depends on 287, 288, 289, 290)

The method of claims 287-290, wherein the linking oligonucleotide comprises a subcode encoding the origin population of the APS or the ESB.

### Claim 292 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290)

The method of claims 261-290, wherein the APS has a subcode encoding the origin population of the APS.

### Claim 293 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292)

The method of claims 261-292, wherein the ESB has a subcode encoding the origin population of the ESB.

### Claim 294 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293)

The method of claims 261-293, wherein an individual APS, ESB, or linking oligonucleotide molecule comprises a unique tag.

### Claim 295 (depends on 294)

The method of claim 294, wherein detection comprises detecting the unique tag.

### Claim 296 (depends on 295)

The method of claim 295, wherein the number of unique tags associated with a specific ESB is determined.

### Claim 297 (depends on 296)

The method of claim 296, wherein the number of detected unique tags relate to the initial quantity of the specific ESB.

### Claim 298 (depends on 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297)

The method of claims 287-297, wherein the ESB is covalently linked to the linking oligonucleotide.

### Claim 299 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298)

The method of claims 261-298, wherein an APS or an ESB comprises an amplification primer binding region.

### Claim 300 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299)

The method of claims 261-299, wherein a COB encodes a peptide sequence.

### Claim 301 (depends on 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300)

The method of claims 261-300, wherein the COB comprises a polymerase start site.

### Claim 302 (depends on 300, 301)

The method of claims 300-301, wherein the peptide comprises an affinity tag.

### Claim 303 (depends on 302)

The method of claim 302, wherein the affinity tag is a His-tag.

### Claim 304 (depends on 261)

The method of claim 261, wherein the two or more samples comprise at least 5 samples.

### Claim 305 (depends on 261)

The method of claim 261, wherein the two or more samples comprise at least 10 samples.

### Claim 306 (depends on 261)

The method of claim 261, wherein the two or more samples comprise at least 20 samples.

### Claim 307 (depends on 261)

The method of claim 261, wherein each of the samples created by the most recent splitting receives a different APS.

### Claim 308

A method for labeling an ESB linked target molecule of a cell in a population of cells with a cell origination barcode (COB), comprising:
separating each cell into an individual reaction volume; and
adding the COB to the ESB via chemical or affinity means.

### Claim 309 (depends on 308)

The method of claim 308, wherein the reaction volume is selected from the group consisting of a microbubble, a microdroplet, a well, a microwell, and an enclosure in a microfluidics device.

### Claim 310

A method comprising disassociating a variety of types of components originating from a cell and placing the components on a particle, wherein the components are labeled on said particle.

### Claim 311 (depends on 310)

The method of claim 310, wherein the labeling comprises labeling according to cell origin.

### Claim 312 (depends on 310, 311)

The method of claims 310-311, wherein the labeling comprises labeling according to component type.
